Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Shinkai · SciRah

Researcher profile · Semantic Scholar

T. Shinkai

Share profile

T. Shinkai — researcher profile on SciRah

h-index: 33
Works: 247
Citations: 4,462

Most-cited papers

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
S. Kudoh, K. Takeda, K. Nakagawa, M. Takada +12 more
2006Journal of Clinical Oncology367 citations Open access
Semantic Scholar
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.
R. Maruyama, Y. Nishiwaki, T. Tamura, N. Yamamoto +16 more
2008Journal of Clinical Oncology365 citations Open access
Semantic Scholar
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.
S. Niho, H. Kunitoh, H. Nokihara, T. Horai +18 more
2012Lung Cancer189 citations Open access
Semantic Scholar
A Phase I Dose-Escalation Study of ZD6474 in Japanese Patients with Solid, Malignant Tumors
T. Tamura, H. Minami, Yasuhide Yamada, N. Yamamoto +11 more
2006Journal of Thoracic Oncology142 citations Open access
Semantic Scholar
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
K. Kubota, T. Hida, S. Ishikura, J. Mizusawa +16 more
2014The Lancet Oncology106 citations
Semantic Scholar
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
K. Inoue, K. Nakagami, Mitsuhiro Mizutani, Y. Hozumi +13 more
2009Breast Cancer Research and Treatment84 citations
Semantic Scholar
A Randomized, Double-Blind, Phase IIa Dose-Finding Study of Vandetanib (ZD6474) in Japanese Patients With Non-Small Cell Lung Cancer
K. Kiura, K. Nakagawa, T. Shinkai, K. Eguchi +9 more
2008Journal of Thoracic Oncology84 citations Open access
Semantic Scholar
Pharmacokinetics of (glycolato-0,0′)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin
Y. Sasaki, T. Tamura, K. Eguchi, T. Shinkai +8 more
2004Cancer Chemotherapy and Pharmacology84 citations
Semantic Scholar
Results of a randomized phase III study to compare the overall survival of gefitinib (IRESSA) versus docetaxel in Japanese patients with non-small cell lung cancer who failed one or two chemotherapy regimens
S. Niho, Y. Ichinose, T. Tamura, N. Yamamoto +6 more
200766 citations
Semantic Scholar
Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition.
S. Sawada, E. Komori, N. Nogami, A. Bessho +4 more
2005Chest63 citations
Semantic Scholar
Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination.
S. Sawada, E. Komori, N. Nogami, Y. Segawa +2 more
2009Lung Cancer54 citations
Semantic Scholar
Phase II study of (glycolate-O,O′) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer
M. Fukuda, T. Shinkai, K. Eguchi, Y. Sasaki +6 more
2008Cancer Chemotherapy and Pharmacology44 citations
Semantic Scholar
Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer
S. Sawada, Eisaku Komori, M. Yamashita, M. Nakata +4 more
2007Surgical Endoscopy41 citations
Semantic Scholar
Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer.
Y. Hamamoto, M. Kataoka, M. Yamashita, T. Shinkai +8 more
2010Japanese Journal of Clinical Oncology39 citations Open access
Semantic Scholar
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel.
I. Sekine, Y. Ichinose, Yutaka Nishiwaki, N. Yamamoto +11 more
2009Annals of Oncology34 citations Open access
Semantic Scholar
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
Koichi Goto, I. Sekine, Y. Nishiwaki, R. Kakinuma +15 more
2004British Journal of Cancer33 citations Open access
Semantic Scholar
Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay
Y. Sasaki, T. Shinkai, K. Eguchi, T. Tamura +3 more
2004Cancer Chemotherapy and Pharmacology33 citations
Semantic Scholar
Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis.
K. Kubota, Y. Ichinose, G. Scagliotti, D. Spigel +12 more
2014Annals of Oncology32 citations Open access
Semantic Scholar
A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy
T. Shinkai, K. Eguchi, Y. Sasaki, T. Tamura +7 more
2004Cancer Chemotherapy and Pharmacology29 citations
Semantic Scholar
Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors
Y. Hamamoto, M. Kataoka, M. Yamashita, N. Nogami +7 more
2012Japanese Journal of Radiology27 citations
Semantic Scholar
Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome.
K. Yamaguchi, N. Shijubo, T. Kodama, K. Mori +6 more
2011Japanese Journal of Clinical Oncology25 citations Open access
Semantic Scholar
Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.
H. Tsukada, A. Yokoyama, K. Goto, T. Shinkai +6 more
2015Japanese Journal of Clinical Oncology24 citations Open access
Semantic Scholar
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function
N. Yamamoto, T. Tamura, M. Maeda, M. Ando +7 more
2004Cancer Chemotherapy and Pharmacology24 citations
Semantic Scholar
Japanese experience of telemedicine in oncology
H. Mizushima, Eiko Uchiyama, Hiroshi Nagata, Y. Matsuno +11 more
2001Int. J. Medical Informatics24 citations
Semantic Scholar
Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
K. Nakagawa, K. Yamazaki, H. Kunitoh, T. Hida +7 more
2008Japanese Journal of Clinical Oncology23 citations Open access
Semantic Scholar
Randomized controlled trial comparing docetaxel (D)-cisplatin (P) combination with D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): JCOG0207
H. Tsukada, A. Yokoyama, Y. Nishiwaki, T. Shinkai +6 more
200720 citations
Semantic Scholar
Small cell carcinoma of the anus in a human HIV carrier: Report of a case
Hideto Nakahara, Y. Moriya, T. Shinkai, T. Hirota
2004Surgery today (Print)20 citations
Semantic Scholar
Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007
N. Takigawa, K. Kiura, Y. Segawa, K. Hotta +16 more
2011Journal of Thoracic Oncology19 citations Open access
Semantic Scholar
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients
N. Takigawa, Y. Segawa, D. Kishino, K. Fujiwara +11 more
2004Cancer Chemotherapy and Pharmacology19 citations
Semantic Scholar
A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.
N. Nogami, K. Hotta, S. Kuyama, K. Kiura +11 more
2011Lung Cancer18 citations Open access
Semantic Scholar
Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan)
M. Sakurai, T. Shinkai, K. Eguchi, Y. Sasaki +9 more
2004Journal of Cancer Research and Clinical Oncology18 citations Open access
Semantic Scholar
Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2‐Positive or HER2‐Low Metastatic/Unresectable Breast Cancer
A. Shimomura, T. Takano, S. Takahashi, Yasuaki Sagara +9 more
2022Clinical pharmacology and therapy17 citations Open access
Semantic Scholar
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507
I. Sekine, Y. Nishiwaki, R. Kakinuma, K. Kubota +12 more
2003British Journal of Cancer17 citations Open access
Semantic Scholar
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment
Y. Hamamoto, M. Kataoka, M. Yamashita, N. Nogami +7 more
2012Japanese Journal of Radiology15 citations
Semantic Scholar
Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer.
Takayasu Kurata, Tomohide Tamura, T. Shinkai, Yuichiro Ohe +8 more
2001Japanese Journal of Clinical Oncology15 citations
Semantic Scholar
Quality of gastric cancer care in designated cancer care hospitals in Japan.
T. Higashi, Fumiaki Nakamura, Y. Shimada, T. Shinkai +18 more
2013International Journal for Quality in Health Care13 citations
Semantic Scholar
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.
T. Shibayama, K. Hotta, N. Takigawa, A. Tada +9 more
2006Lung Cancer13 citations
Semantic Scholar
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience
Y. Kato, K. Hotta, N. Takigawa, N. Nogami +9 more
2014Cancer Chemotherapy and Pharmacology11 citations
Semantic Scholar
Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502.
T. Seto, T. Yamanaka, I. Wasada, N. Seki +9 more
2010Lung Cancer11 citations
Semantic Scholar
Long-Term Administration of Second-Line Chemotherapy with S-1 and Gemcitabine for Platinum-Resistant Non-small Cell Lung Cancer: A Phase II Study
Y. Takiguchi, T. Seto, Y. Ichinose, N. Nogami +8 more
2011Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
A randomized double-blind phase IIa dose-finding study of ZD6474 in Japanese patients with NSCLC.
Kazuo Nakagawa, K. Kiura, T. Shinkai, K. Eguchi +6 more
2006Journal of Clinical Oncology10 citations
Semantic Scholar
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer.
N. Takigawa, K. Kiura, K. Hotta, S. Hosokawa +13 more
2011Lung Cancer9 citations
Semantic Scholar
Cytogenetic effect of carboplatin on human lymphocytes
T. Shinkai, N. Saijo, K. Eguchi, Y. Sasaki +7 more
2004Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).
H. Katayama, J. Mizusawa, H. Fukuda, Shinichiro Nakamura +14 more
2021Japanese Journal of Clinical Oncology8 citations
Semantic Scholar
Abstract P1-18-12: A phase 1, multicenter, open-label study to assess the effect of [fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) on QTc and pharmacokinetics in subjects with HER2-expressing metastatic and/or unresectable breast cancer
T. Yamashita, A. Shimomura, T. Takano, Yasuaki Sagara +8 more
20208 citations
Semantic Scholar
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015
T. Kozuki, N. Nogami, Hiromoto Kitajima, S. Iwasawa +9 more
2016BMC Cancer8 citations Open access
Semantic Scholar
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.
K. Hotta, N. Takigawa, K. Kiura, M. Tabata +11 more
2005Anticancer Research8 citations
Semantic Scholar
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer
S. Umemura, Y. Segawa, H. Ueoka, K. Hotta +6 more
2007Journal of Cancer Research and Clinical Oncology7 citations Open access
Semantic Scholar
Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy
Y. Hamamoto, M. Kataoka, N. Nogami, T. Kozuki +3 more
2012Japanese Journal of Radiology5 citations
Semantic Scholar
A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
N. Nogami, K. Kiura, N. Takigawa, S. Harita +6 more
20105 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Saijo×16
Invite
N. Saijo — researcher profile on SciRah
K. Eguchi×14
Invite
K. Eguchi — researcher profile on SciRah
T. Tamura×13
Invite
T. Tamura — researcher profile on SciRah
N. Nogami×13
Invite
N. Nogami — researcher profile on SciRah

×12

Invite

K. Kiura — researcher profile on SciRah

Invite

Y. Ohe — researcher profile on SciRah

K. Nakagawa×10

Invite

K. Nakagawa — researcher profile on SciRah

Invite

N. Takigawa — researcher profile on SciRah

Invite

M. Tabata — researcher profile on SciRah

Invite

Y. Ichinose — researcher profile on SciRah

Invite

Y. Segawa — researcher profile on SciRah

Invite

K. Hotta — researcher profile on SciRah